Kelkheim, Germany

Markus Krüer

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Merz Pharma Gmbh & Co Kgaa, Merz Pharma Gmbh & Co. Kgaa. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Krüer. Retrieved from https://idiyas.com/inventor/markus-krüer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Markus Krüer in the Field of Medicine

Introduction

Markus Krüer is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the medical field, particularly in the treatment of sialorrhea, a condition characterized by excessive saliva production. His innovative approach utilizes botulinum neurotoxins, showcasing his expertise and dedication to improving patient care.

Latest Patents

Markus Krüer holds 1 patent for his invention titled "Use of botulinum neurotoxin in the treatment of sialorrhea." This patent focuses on enhanced methods of administering botulinum neurotoxins specifically into the parotid and submandibular glands. The invention details a precise dose ratio between 1.45 to 1 and 1.7 to 1, which aims to optimize treatment outcomes for patients suffering from this condition.

Career Highlights

Throughout his career, Markus has been associated with Merz Pharma GmbH & Co. KGaA, a company renowned for its commitment to developing innovative medical solutions. His work at Merz Pharma has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.

Collaborations

Some of Markus Krüer's notable coworkers include Janos Csikos and Irena Pulte. Their collaborative efforts have played a crucial role in advancing research and development in the area of botulinum neurotoxins.

Conclusion

Markus Krüer's innovative work in the treatment of sialorrhea through the use of botulinum neurotoxins exemplifies his commitment to improving medical treatments. His contributions are significant in the ongoing pursuit of effective solutions for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…